Yes, cephalexin is an appropriate and effective antibiotic for treating an infected insect bite with lymphangitic streaking in an otherwise healthy 11-year-old child.
Cephalexin is specifically recommended as first-line oral therapy for typical cellulitis (which includes infected insect bites with lymphangitic streaking) and is FDA-approved for skin and soft tissue infections caused by Staphylococcus aureus and Streptococcus pyogenes—the primary pathogens in these infections 1, 2.
Why Cephalexin is the Right Choice
The IDSA guidelines explicitly list cephalexin among the preferred oral antibiotics for typical cellulitis, which encompasses your clinical scenario 1. The presence of lymphangitic streaking indicates superficial lymphatic involvement, which is a classic feature of cellulitis/erysipelas and does not change the treatment approach—it remains a streptococcal infection requiring beta-lactam coverage 1.
Key Clinical Points:
No MRSA coverage needed: For typical cellulitis without purulent drainage, penetrating trauma, or IV drug use, MRSA coverage is unnecessary. The IDSA guidelines note that beta-lactam therapy (like cephalexin) was successful in 96% of cellulitis cases, confirming MRSA is an uncommon cause of typical cellulitis 1.
Streptococcal coverage is essential: The primary pathogen in cellulitis with lymphangitic streaking is beta-hemolytic streptococci, and cephalexin provides excellent coverage 1, 2.
Dosing Recommendations
For an 11-year-old with moderate cellulitis:
- Standard dosing: 25-50 mg/kg/day divided into 3-4 doses (maximum 4 g/day) 2
- High-dose option: Recent pediatric data supports 45 mg/kg/dose three times daily (maximum 1.5 g per dose) for more severe infections, with 89.7% success rates in moderate cellulitis 3, 4
- Duration: 5 days is as effective as 10 days if clinical improvement occurs by day 5 1
Important Caveats
When to reconsider or add MRSA coverage:
- Purulent drainage develops
- No improvement after 48-72 hours of cephalexin
- History of MRSA infection
- Penetrating trauma was involved
If MRSA coverage becomes necessary, add trimethoprim-sulfamethoxazole or switch to clindamycin while maintaining streptococcal coverage 1.
Monitoring: Follow the patient closely for worsening symptoms in the first 24-48 hours, as inflammation may temporarily worsen due to bacterial lysis releasing inflammatory enzymes 1. This does not indicate treatment failure unless accompanied by systemic deterioration.
No cultures needed: Blood cultures and tissue aspirates are unnecessary for typical cellulitis in an otherwise healthy child without severe systemic features 1.